While reporting its financial results for the fourth quarter on Wednesday, Teva Pharmaceutical Industries Ltd (TEVA) forecast fiscal 2021 revenues in a range of $16.4 billion to $16.8 billion, and adjusted earnings per share in a range of $2.50 to $2.70. This compares to revenues of $16.7 billion and adjusted earnings per share of $2.57 per share for fiscal 2020.
from RTT - Earnings https://ift.tt/2Ok919T
via IFTTT
No comments:
Post a Comment